Summary & Overview
HCPCS J1941: Injection, Furosemide (Furoscix), 20 mg
HCPCS Level II code J1941 designates the injection of furosemide (Furoscix), 20 mg. This code captures a specific injectable diuretic formulation used for fluid management and symptomatic relief of volume overload, making it relevant across acute care, infusion, and home-based settings. Nationally, injectable diuretics are important for rapid management of edema and congestive symptoms and for enabling alternative care pathways outside inpatient settings.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for injectable furosemide, expected sites of service, and the common payer landscape affecting coverage and billing. The publication also outlines benchmarking and reimbursement considerations where available, variations in payer policy approaches, and policy updates that affect coding and claims processing for HCPCS Level II code J1941.
The content provides practical reference points for billing professionals, revenue cycle staff, and clinical managers seeking clarity on the code’s scope, common clinical uses, and payer coverage environment. Data not available in the input will be explicitly noted where applicable.
Billing Code Overview
HCPCS Level II code J1941 represents the injection of furosemide (Furoscix), 20 mg. The service is a pharmacologic/therapeutic injection intended for diuresis and fluid management in clinical settings. Typical sites of service include outpatient infusion clinics, emergency departments, physician offices, and home health or home infusion settings where subcutaneous or injectable diuretic therapy may be administered.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with acute decompensated heart failure or symptomatic volume overload who requires rapid diuresis. The patient presents to an infusion center, emergency department, observation unit, or skilled nursing facility with peripheral edema, pulmonary congestion, or ascites not adequately controlled by oral diuretics. A clinician assesses vital signs, renal function, electrolytes, and current medications, documents indications and risks, obtains informed consent, and orders a subcutaneous furosemide injection using the J1941 product (20 mg furoscix). Nursing prepares the device per manufacturer instructions, selects an appropriate subcutaneous site (abdomen or lateral thigh), administers the injection or places the subcutaneous infusion device, monitors for local site reactions, checks urine output and hemodynamics, repeats laboratory monitoring (serum creatinine, BUN, electrolytes), and documents response to treatment and any adverse events in the medical record. Typical workflow steps include order entry, pre-administration assessment, medication administration by a licensed clinician, post-administration monitoring, and billing using J1941 with any applicable modifiers for payer reporting.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard billing |